Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 May;17(5):260-3.
doi: 10.1023/a:1009406315729.

Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction

Affiliations
Comparative Study

Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction

G E Fiszbajn et al. J Assist Reprod Genet. 2000 May.

Abstract

Purpose: To compare the efficiency of transvaginal ultrasound-guided functional ovarian cyst aspiration, with conservative management, in the outcome of patients undergoing assisted reproductive technique (ART) (in vitro fertilization or intracytoplasmic sperm injection). These cysts were identified before ovarian stimulation begun and after administration of a midluteal GnRH agonist.

Methods: Fifty nine patients undergoing ART from January 1, 1997 to February 28, 1999, who developed functional ovarian cysts were included. Aspirations of these cysts (n = 14) versus conservative management (observation) (n = 45) were compared. Total number of ovarian follicles developed, number of oocytes retrieved, estradiol levels on the day of human chorionic gonadotropin, fertilization rate, number of good quality embryos transferred, implantation, and clinical pregnancy rate per cycle were evaluated.

Results: No statistical differences were observed between the two groups in any of the selected parameters.

Conclusions: Cyst aspiration and conservative management showed similar implantation and pregnancy rates, in patients who develop functional ovarian cysts after pituitary down-regulation following luteal phase gonadotropin-releasing hormone agonist administration. Prospective studies are needed to confirm this trend.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins. Lancet. 1984;2:1284–1285. - PubMed
    1. Waegemaekers CT, Van-de-Berg A, Helmerhorst FM, Naaktgeborn N. Ovarian cyst formation during the use of GnRH analogue in an IVF program. Acta Eur Fertil. 1987;18:411–417. - PubMed
    1. Feldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA. Ovarian cyst formation: A complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril. 1989;51:42–45. - PubMed
    1. Herman A, Ron-El R, Golan A, Nahum H, Soffer Y, Caspi E. Follicle cyst after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization. Fertil Steril. 1990;53:854–858. - PubMed
    1. Jenkins JM, Anthony FW, Wood P, Rushen D, Masson GM, Thomas E. The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod. 1993;8:1623–1627. - PubMed

Publication types

MeSH terms

LinkOut - more resources